ArcherDx, Inc.
ArcherDx, Inc., a leading player in the precision medicine industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2013, the company has rapidly established itself as a pioneer in genomic profiling and next-generation sequencing technologies, focusing on oncology and rare diseases. ArcherDx is renowned for its innovative products, including the Archer FusionPlex and Archer VariantPlex assays, which enable comprehensive genomic analysis with unparalleled accuracy and sensitivity. These offerings are distinguished by their ability to detect a wide range of genetic alterations, making them invaluable tools for personalised cancer treatment. With a strong market position, ArcherDx has achieved notable milestones, including strategic partnerships and collaborations that enhance its research capabilities and expand its global reach. The company continues to drive advancements in molecular diagnostics, solidifying its reputation as a trusted leader in the field.
DitchCarbon Score
How does ArcherDx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ArcherDx, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ArcherDx, Inc.'s reported carbon emissions
ArcherDx, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of specific initiatives or targets, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and reducing their environmental impact. ArcherDx may be engaging in similar efforts, but further information would be required to provide a comprehensive overview of their climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ArcherDx, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
